Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshio Sumida

Showing results (131-140 of 220) with videos related to

Pageof 22
Sort By:
Journal of Gastroenterology and Hepatology|July 7, 2020
Patient-reported outcomes in patients with non-alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire-non-alcoholic fatty liver disease/non-alcoholic steatohepatitisSakura Yamamura, Dan Nakano, Ryuki Hashida, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 24, 2023
Agile 3+ and Agile 4, noninvasive tests for liver fibrosis, are excellent formulae to predict liver-related events in nonalcoholic fatty liver diseaseKouichi Miura, Hideki Hayashi, Yoshihiro Kamada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 29, 2014
Serum alanine aminotransferase predicts the histological course of non-alcoholic steatohepatitis in Japanese patientsYuya Seko, Yoshio Sumida, Saiyu Tanaka, et al.
Journal of Gastroenterology|March 30, 2024
iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction: a multicenter studyMasashi Hirooka, Sadanobu Ogawa, Yohei Koizumi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 5, 2010
Lower circulating levels of dehydroepiandrosterone, independent of insulin resistance, is an important determinant of severity of non-alcoholic steatohepatitis in Japanese patientsYoshio Sumida, Yoshikazu Yonei, Kazuyuki Kanemasa, et al.
Journal of Gastroenterology|August 27, 2013
The association of insomnia with gastroesophageal reflux symptoms in biopsy-proven nonalcoholic fatty liver diseaseHiroyoshi Taketani, Yoshio Sumida, Saiyu Tanaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 20, 2017
Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non-alcoholic fatty liver diseaseYuya Seko, Yoshio Sumida, Saiyu Tanaka, et al.
Cancer Science|May 12, 2015
EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor-β-mediated growth inhibition in hepatocellular carcinomaKohichiroh Yasui, Chika Konishi, Yasuyuki Gen, et al.
Scientific Reports|July 29, 2018
Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxinYuji Ogawa, Kento Imajo, Yasushi Honda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 29, 2014
Lower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of non-alcoholic fatty liver diseaseYoshio Sumida, Yoshikazu Yonei, Saiyu Tanaka, et al.
Pageof 22

Showing results (131-140 of 220) with videos related to

Sort By:
Pageof 22
Journal of Gastroenterology and Hepatology|July 7, 2020
Patient-reported outcomes in patients with non-alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire-non-alcoholic fatty liver disease/non-alcoholic steatohepatitisSakura Yamamura, Dan Nakano, Ryuki Hashida, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 24, 2023
Agile 3+ and Agile 4, noninvasive tests for liver fibrosis, are excellent formulae to predict liver-related events in nonalcoholic fatty liver diseaseKouichi Miura, Hideki Hayashi, Yoshihiro Kamada, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 29, 2014
Serum alanine aminotransferase predicts the histological course of non-alcoholic steatohepatitis in Japanese patientsYuya Seko, Yoshio Sumida, Saiyu Tanaka, et al.
Journal of Gastroenterology|March 30, 2024
iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction: a multicenter studyMasashi Hirooka, Sadanobu Ogawa, Yohei Koizumi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 5, 2010
Lower circulating levels of dehydroepiandrosterone, independent of insulin resistance, is an important determinant of severity of non-alcoholic steatohepatitis in Japanese patientsYoshio Sumida, Yoshikazu Yonei, Kazuyuki Kanemasa, et al.
Journal of Gastroenterology|August 27, 2013
The association of insomnia with gastroesophageal reflux symptoms in biopsy-proven nonalcoholic fatty liver diseaseHiroyoshi Taketani, Yoshio Sumida, Saiyu Tanaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 20, 2017
Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non-alcoholic fatty liver diseaseYuya Seko, Yoshio Sumida, Saiyu Tanaka, et al.
Cancer Science|May 12, 2015
EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor-β-mediated growth inhibition in hepatocellular carcinomaKohichiroh Yasui, Chika Konishi, Yasuyuki Gen, et al.
Scientific Reports|July 29, 2018
Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxinYuji Ogawa, Kento Imajo, Yasushi Honda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 29, 2014
Lower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of non-alcoholic fatty liver diseaseYoshio Sumida, Yoshikazu Yonei, Saiyu Tanaka, et al.
Pageof 22